Ushanti Colour Chem FY26 Revenue Rises to ₹128.82 Crore
Key highlights
- Ushanti Colour Chem reported FY26 revenue of ₹128.82 crore, versus ₹51.89 crore in FY25.
- FY26 net profit was ₹5.03 crore, compared with ₹1.81 crore in FY25.
- H2 FY26 sales were ₹83.82 crore and operating margin was 0.8%.
- Ushanti Colour Chem approved H1 FY27 results on November 5, 2026 and appointed a new auditor subject to shareholder approval.
powered by IRIS
Ushanti Colour Chem Limited reported FY26 revenue of ₹128.82 crore, up from ₹51.89 crore in FY25, while net profit rose to ₹5.03 crore from ₹1.81 crore. The FY26 annual figures show a sharp increase in reported scale, though half-year operating margins remained narrow through the period disclosed.
Know Ushanti Colour Chem inside out
Results, valuation, peers and who's buying, in one view.
What did Ushanti Colour Chem report for FY26?
Ushanti Colour Chem Limited, referred to as UCL, reported standalone FY26 revenue of ₹128.82 crore, EBITDA of ₹8.43 crore and net profit of ₹5.03 crore. In FY25, UCL had reported revenue of ₹51.89 crore, EBITDA of ₹4.66 crore and net profit of ₹1.81 crore. Earnings per share increased to ₹4.43 in FY26 from ₹1.67 in FY25.
The annual data shows FY26 revenue was more than double the FY25 level. The company’s reported EBITDA also increased from ₹4.66 crore to ₹8.43 crore over the same comparison. These figures are drawn from the annual-results table supplied for the years ended March 2022 through March 2026.
How did UCL's half-year sales and operating profit move?
UCL's disclosed half-year sales rose from ₹37.00 crore in H1 FY25 to ₹55.07 crore in H1 FY26, and then to ₹83.82 crore in H2 FY26. The H2 FY26 sales figure was higher than ₹41.13 crore reported in H2 FY25, according to the half-year table.
Operating profitability remained limited in these reported periods. Operating profit was negative ₹0.40 crore in H1 FY26, compared with a positive ₹1.13 crore in H2 FY25, before returning to a positive ₹0.72 crore in H2 FY26. Operating margin was negative 0.7% in H1 FY26 and 0.8% in H2 FY26. This indicates that higher sales did not translate into a proportionate expansion in operating margin during the reported halves.
What was decided at the November 5 board meeting?
UCL approved its unaudited standalone and consolidated financial results for the half year ended September 30, 2026, at a board meeting held on November 5, 2026. The supplied announcement does not provide the detailed profit-and-loss figures for that H1 FY27 result within the available material.
The board also recorded the resignation of statutory auditor M/s DJNV & Co., effective November 5, 2026. The auditor cited the planned dissolution of its audit firm. UCL appointed M/s Bansi S. Mehta & Co. to fill the casual vacancy for the financial year ending March 31, 2027, subject to shareholder approval.
Got a follow-up? Ask IRIS
What has UCL said about FY27 operations?
UCL has said it expects revenue growth in FY27 through lower costs, higher local and export sales, and modernised processes. The company did not provide a numerical FY27 revenue target, margin target, or profit forecast in the supplied information.
The company also disclosed warrant proceeds of ₹15.40 crore. Of this amount, ₹6.80 crore was intended for investment in, or advances to, its subsidiary, and ₹4.40 crore had been used by March 2026. The disclosed utilisation provides a reference point for investors tracking how the capital raised is deployed.
Why do the reported figures matter to investors?
The annual results show a substantial increase in UCL's FY26 reported revenue and net profit against FY25. At the same time, the half-year operating data shows margins between negative 0.7% and 2.7% across H1 FY25 to H2 FY26. Revenue growth and operating-margin movement therefore need to be considered together when assessing the financial trend.
The supplied market data placed UCL's share price at ₹194 and market capitalisation at ₹269 crore. It also described the price-to-earnings multiple as not meaningful. Investors should rely on UCL's exchange filings for verified quarterly and half-yearly details, particularly because some supplied data summaries use different period labels and figures.
Conclusion
UCL's FY26 annual table reports revenue of ₹128.82 crore, EBITDA of ₹8.43 crore and net profit of ₹5.03 crore, all above FY25 levels. However, the reported half-year figures show that operating profitability remained thin despite sales growth, making margin performance an important part of the financial picture.
The next disclosed point to watch is the company’s financial reporting after its November 5, 2026 board meeting, including detailed H1 FY27 filings if released. Investors can also track shareholder approval of the new statutory auditor and the further use of warrant proceeds, including the balance earmarked for the subsidiary.